Remdesivir Demonstrates Further Promise

June 18, 2020

Remdesivir Demonstrates Further Promise

Gilead Science’s antiviral COVID treatment, remdesivir, effectively prevents lung damage in macaque monkeys infected with coronavirus, according to findings published in Nature. Yourway offers direct-to-patient services to help trials continue to run and provide convenience for patients when they can’t leave their homes.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Precision in Pharma Supply Chain & Logistics Summit

November 17-18, 2025
Revere Hotel Boston Common

Schedule a Meeting

SCOPE Supply Chain & Logistics Leadership Summit

February 2-5, 2026
Orlando, Florida

Schedule a Meeting

Media

Articles

Mitigating Risk in Drug Development: The Strategic Role of Phase I Research Units

Open chat

Hello! How can I help you?